Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11416)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu JI, Park HC. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2016; 22(30): 6851-6863 [PMID: 27570422 DOI: 10.3748/wjg.v22.i30.6851] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i30/6851.htm |
| Number | Citing Articles |
| 1 |
Jina Kim, Jason Chia-Hsien Cheng, Taek-Keun Nam, Jin Hee Kim, Byoung Kuk Jang, Wen-Yen Huang, Hiroshi Aikata, Myungsoo Kim, Jung Hyun Kwon, Jinbo Yue, Victor Ho Fun Lee, Zhaochong Zeng, Jinsil Seong. Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers 2023; 15(12): 3164 doi: 10.3390/cancers15123164
|
| 2 |
Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1. International Journal of Radiation Oncology*Biology*Physics 2021; 110(2): 510 doi: 10.1016/j.ijrobp.2020.12.031
|
| 3 |
Seungji Lee, Sung Kyu Song, Byungje Bae, Yongkeun Park. Comparing efficacies of different treatment regimens in patients with hepatocellular carcinoma accompanied by portal vein tumor thrombus using network meta-analysis. Annals of Surgical Treatment and Research 2022; 103(5): 280 doi: 10.4174/astr.2022.103.5.280
|
| 4 |
雍博 周. Progress in Transformation Therapy of Hepatocellular Carcinoma with Portal Vein Cancer Thrombus. Advances in Clinical Medicine 2022; 12(12): 11521 doi: 10.12677/ACM.2022.12121661
|
| 5 |
Gyu Sang Yoo, Jeong Il Yu, Sungkoo Cho, Sang Hoon Jung, Youngyih Han, Seyjoon Park, Yoonjin Oh, Boram Lee, Hee Chul Park, Do Hoon Lim, Moon Seok Choi, Hojeong Won. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma. Radiotherapy and Oncology 2020; 146: 187 doi: 10.1016/j.radonc.2020.02.019
|
| 6 |
Seo Hee Choi, Jinsil Seong. Strategic application of radiotherapy for hepatocellular carcinoma. Clinical and Molecular Hepatology 2018; 24(2): 114 doi: 10.3350/cmh.2017.0073
|
| 7 |
Junqing Lin, Han Jiang, Weizhu Yang, Na Jiang, Qubin Zheng, Ning Huang, Xiaolong Wang, Ang Li, Jingyao Huang. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy 2019; 18(2): 233 doi: 10.1016/j.brachy.2018.10.002
|
| 8 |
Aoran Dong, Meiyan Zhu, Zeyu Zhang, Wenzhe Fan, Zhiqiang Wu, Yong Chen, Jianfei Tu, Yaojun Zhang, Wenquan Zhuang, Xiaofang He, Zhenwei Peng. Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1320818
|
| 9 |
Minah Kang, Yerim Shin, Yeseul Kim, Sangseok Ha, Wonmo Sung. Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma. Bioengineering 2024; 11(2): 106 doi: 10.3390/bioengineering11020106
|
| 10 |
Juxian Sun, Rongping Guo, Xinyu Bi, Mengchao Wu, Zhaoyou Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong, Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Gong Li, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Huichuan Sun, Kaishan Tao, Gaojun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xuting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhaochong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition). Liver Cancer 2022; 11(4): 315 doi: 10.1159/000523997
|
| 11 |
Changcheng Tao, Kai Zhang, Zonggui Tao, Yue Liu, Anke Wu, Liming Wang, Qinfu Feng, Fan Wu, Weiqi Rong, Jianxiong Wu. Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion. Cancer Reports 2024; 7(1) doi: 10.1002/cnr2.1928
|
| 12 |
Xing-Hao Zhou, Jing-Ru Li, Tang-Hui Zheng, Hong Chen, Chen Cai, Sheng-Long Ye, Bo Gao, Tong-Chun Xue. Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy. Clinical & Experimental Metastasis 2023; 40(1): 5 doi: 10.1007/s10585-022-10188-1
|
| 13 |
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
|
| 14 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park, Dongho Hyun, Woo Kyoung Jeong, Ho Yeong Lim, Moon Seok Choi, Sang Yun Ha. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?. Cancers 2020; 12(9): 2395 doi: 10.3390/cancers12092395
|
| 15 |
Shingo Ohira, Naoyuki Kanayama, Kentaro Wada, Toshiki Ikawa, Takero Hirata, Noriko Kishi, Tsukasa Karino, Hayate Washio, Yoshihiro Ueda, Masayoshi Miyazaki, Masahiko Koizumi, Teruki Teshima, Dong-Hoon Lee. Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography. PLOS ONE 2021; 16(1): e0244079 doi: 10.1371/journal.pone.0244079
|
| 16 |
Takuji Torimura, Hideki Iwamoto. Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver International 2022; 42(9): 2042 doi: 10.1111/liv.15130
|
| 17 |
Xiaolong Li, Weixing Guo, Lei Guo, Wan Yee Lau, Naijian Ge, Kang Wang, Shuqun Cheng. Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study. Oncotarget 2018; 9(36): 24537 doi: 10.18632/oncotarget.25224
|
| 18 |
Heng Zhang, Gang Chen, Xing Feng, Huiwen Song, Lingbing Meng, Yao Fu, Jun Yang, Zhiwen Fan, Youxiang Ding, Zhijie Du, Jianchao Wang, Li Yang, Jun Zhang, Lixia Sun, Zhigang Liu, Zhiyong Zhang, Quanhai Li, Xiangshan Fan. Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression. EMBO Molecular Medicine 2023; 15(5) doi: 10.15252/emmm.202215924
|
| 19 |
Ze-Xin Zhu, Xiao-Xue Wang, Ke-Fei Yuan, Ji-Wei Huang, Yong Zeng. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB 2018; 20(9): 795 doi: 10.1016/j.hpb.2018.03.015
|
| 20 |
Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Takuya Nagano, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Akihiko Hoshi, Masayuki Kurosaki, Namiki Izumi. Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis. Hepatology Research 2020; 50(12): 1375 doi: 10.1111/hepr.13567
|
| 21 |
Yung‐Ning Huang, Yang‐Bor Lu, Sheng‐Nan Lu. Sequential bilateral PVTT successfully controlled by radiotherapy and sorafenib, respectively. The Kaohsiung Journal of Medical Sciences 2019; 35(1): 63 doi: 10.1016/j.kjms.2018.06.003
|
| 22 |
Chen Wang, Wansheng Wang, Jian Shen, Baosheng Ren, Xiaoli Zhu, Caifang Ni. Feasibility of Helical I-125 Seed Implant in the Portal Vein. CardioVascular and Interventional Radiology 2019; 42(1): 121 doi: 10.1007/s00270-018-2059-0
|
| 23 |
Ning Sun, Jialin Zhang, Baifeng Li, Ailin Li, Mutian Lv, Chengshuo Zhang. Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasis. Medicine 2021; 100(49): e27987 doi: 10.1097/MD.0000000000027987
|
| 24 |
Ji-Rong Li, Min-Jiang Wu, Tan Wang, Min Tian, Guang Zhou, Qing-Xiong Liu, Xian-Hong Xiang, Ying-Qiang Zhang. A prognostic score model for predicting the survival benefits of patients undergoing sorafenib plus transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion. Abdominal Radiology 2021; 46(5): 1967 doi: 10.1007/s00261-020-02897-6
|
| 25 |
Jeong Il Yu, Hee Chul Park, Sang Hoon Jung, Changhoon Choi, Sung Wook Shin, Sung Ki Cho, Dong Hyun Sinn, Yong-Han Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Hüseyin Sahinbas, Seung Woon Paik. Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial. Oncotarget 2017; 8(32): 52651 doi: 10.18632/oncotarget.17072
|
| 26 |
Shuheng Bai, YinYing Wu, Yanli Yan, Rong Li, Haojing Kang, Jiangzhou Zhang, Wen Ma, Ying Gao, Beina Hui, Hailin Ma, Xiaozhi Zhang, Juan Ren. Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/1533033821995286
|
| 27 |
Yingqiang Zhang, Hongfei Miao, Wenlin Xie, Suxiang Jiang, Ze Song, Guihua Huang, Wenzhe Fan, Yu Wang, Jiaping Li, Yong Chen. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization. European Radiology 2021; 31(1): 232 doi: 10.1007/s00330-020-07078-z
|
| 28 |
Jin‐Cheng Wang, An‐Liang Xia, Yong Xu, Xiao‐Jie Lu. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Cellular Physiology 2019; 234(2): 1062 doi: 10.1002/jcp.27324
|
| 29 |
Jian Lu, Xiu-Ping Zhang, Bin-Yan Zhong, Wan Yee Lau, David C Madoff, Jon C Davidson, Xiaolong Qi, Shu-Qun Cheng, Gao-Jun Teng. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. The Lancet Gastroenterology & Hepatology 2019; 4(9): 721 doi: 10.1016/S2468-1253(19)30178-5
|
| 30 |
Xiaojie Li, Zhimin Ye, Sheng Lin, Haowen Pang. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08469-1
|
| 31 |
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
|
| 32 |
Jaehun Yang, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh. Surgical Resection Is Preferred in Selected Solitary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Digestive Surgery 2022; 39(1): 42 doi: 10.1159/000521827
|
| 33 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Current role of proton beam therapy in patients with hepatocellular carcinoma. International Journal of Gastrointestinal Intervention 2021; 10(4): 175 doi: 10.18528/ijgii210043
|
| 34 |
Fei‐Pang Kuo, Tzu‐Hsuan Cheng, Yu‐Ming Cheng, Chao‐Chuan Wu, Chia‐Chi Wang. Effectiveness of multimodality treatment for hepatocellular carcinoma patients with portal vein thrombosis: A real world experience. Advances in Digestive Medicine 2022; 9(3): 168 doi: 10.1002/aid2.13275
|
| 35 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. World Journal of Gastroenterology 2018; 24(28): 3090-3100 doi: 10.3748/wjg.v24.i28.3090
|
| 36 |
Min Zhang, Zhuangzhuang Zheng, Qiuhui Ding, Jing Su, Ying Xin, Xin Jiang. Radiotherapy plus lenvatinib versus radiotherapy plus sorafenib for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1458819
|
| 37 |
Yongjie Shui, Wei Yu, Xiaoqiu Ren, Yinglu Guo, Jing Xu, Tao Ma, Bicheng Zhang, Jianjun Wu, Qinghai Li, Qiongge Hu, Li Shen, Xueli Bai, Tingbo Liang, Qichun Wei. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Radiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1136-5
|
| 38 |
Peter R. Galle, Francesco Tovoli, Friedrich Foerster, Marcus A. Wörns, Alessandro Cucchetti, Luigi Bolondi. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. Journal of Hepatology 2017; 67(1): 173 doi: 10.1016/j.jhep.2017.03.007
|
| 39 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 40 |
Fangzhou Luo, Mengxia Li, Jun Ding, Shusen Zheng. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.635731
|
| 41 |
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study. Clinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
|
| 42 |
Lei Guo, Xubiao Wei, Shuang Feng, Jian Zhai, Weixing Guo, Jie Shi, Wan Yee Lau, Yan Meng, Shuqun Cheng. Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial. Hepatology International 2022; 16(6): 1368 doi: 10.1007/s12072-022-10423-7
|
| 43 |
Wansheng Wang, Jian Shen, Chen Wang, Baosheng Ren, Xiaoli Zhu, Caifang Ni. Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2019; 42(10): 1420 doi: 10.1007/s00270-019-02256-z
|
| 44 |
Xuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju. Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.793581
|
| 45 |
Scott M. Thompson, Michael L. Wells, James C. Andrews, Eric C. Ehman, Christine O. Menias, Christopher L. Hallemeier, Lewis R. Roberts, Sudhakar K. Venkatesh. Venous invasion by hepatic tumors: imaging appearance and implications for management. Abdominal Radiology 2018; 43(8): 1947 doi: 10.1007/s00261-017-1298-x
|
| 46 |
Shuqun Cheng, Minshan Chen, Jianqiang Cai, Juxian Sun, Rongping Guo, Xinyu Bi, Wan Yee Lau, Mengchao Wu. Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer 2020; 9(1): 28 doi: 10.1159/000503685
|
| 47 |
Yu-Ming Huang, Tsang-En Wang, Ming-Jen Chen, Ching-Chung Lin, Ching-Wei Chang, Hung-Chi Tai, Shih-Ming Hsu, Yu-Jen Chen. Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906498
|
| 48 |
Jeong Il Yu, Su Jin Lee, Jeeyun Lee, Ho Yeong Lim, Seung Woon Paik, Gyu Sang Yoo, Changhoon Choi, Hee Chul Park. Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma. Cancer Medicine 2019; 8(16): 6986 doi: 10.1002/cam4.2570
|
| 49 |
Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?. Liver Research 2024; 8(3): 141 doi: 10.1016/j.livres.2024.09.002
|
| 50 |
John Chun-Hao Chen, Shih-Hua Liu, Tsung-Yu Yen, Kun-Yao Dai, Jeng-Jong Hwang, Yu-Jen Chen. Sorafenib-Induced Radiation in-Field Skin (SIRIS) Reaction: Unexpected Complication in Elder Hepatocellular Carcinoma Patients Received Sorafenib and Concurrent Radiation Therapy. International Journal of Gerontology 2018; doi: 10.1016/j.ijge.2018.03.008
|